Cannabidiol (CBD) has been having an outstanding decade. The cannabis extract is still very divisive, but over the years, it has been able to worm its way into people’s hearts. The compound has proven itself quite effective against a host of medical conditions, ranging from chronic pain, anxiety, and depression to high blood pressure and seizures. A product so versatile could hide for only so long, and as word of its range of benefits spreads, demand for the product will only increase.
In a bid to exploit this market and give farmers all over the country the opportunity to invest in a new profitable cash crop, Congress passed the Farm Bill in 2018, in effect legalizing the cultivation of hemp, the plant responsible for producing CBD. Earlier this week, the USDA passed…
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor